跳至主要内容
临床试验/NCT00975117
NCT00975117已完成3 期

Assessment of the Efficacy of Dietary Supplement Spermotrend in the Treatment of Male Infertility

Catalysis SL2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Catalysis SL
入组人数
86
试验地点
2
主要终点
Parameters of seminal analysis at weeks 24

研究概览

简要总结

The purpose of this study is to determine whether the administration of the dietary supplement Spermotrend improves spermatogenesis parameters in subjects with male infertility unrelated to major testicular conditions. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks. The estimated number of males with infertility to be recruited and randomized for the study is 86.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
19 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male infertility unrelated to major testicular conditions
  • Must have at least one altered seminal parameter.
  • Signed informed consent

排除标准

  • Hydrocele, varicocele, orchitis, epididymitis, irradiation or Chemotherapy.
  • Previously treated and cured testicular condition.
  • Non-transmissible chronic diseases
  • Use of antioxidant agents within 6 months.
  • Use of vitamins within 6 months.
  • Use of anti-inflammatory drugs within 6 months.
  • Use of hormones prescribed by an andrologist within 6 months
  • Positive serology/HIV
  • Leukocytospermia

结局指标

主要结局

Parameters of seminal analysis at weeks 24

时间窗: 24 weeks

次要结局

  • Fertilization achievement(24 weeks)
  • Presence of mild or severe adverse effects(24 weeks)

研究者

发起方
Catalysis SL
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

Spermotrend in the Treatment of Male Infertility | 临床试验